Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Makoto, Ideguchi"'
Autor:
Kenji Yoshida, Tomoyuki Akita, Kosuke Katayama, Kiyohide Kakuta, Takafumi Nishizaki, Fumiyuki Yamasaki, Hirotaka Fudaba, Kenichiro Asano, Takashi Sasayama, Manabu Natsumeda, Taichi Shimabukuro, Kotaro Taguchi, Shinichiro Koizumi, Noriyuki Nakayama, Kentaro Fujii, Ikuno Nishibuchi, Kazuhiko Sugiyama, Ushio Yonezawa, Momii Yasutomo, Yukari Kawasaki, Kazuhiro Tanaka, Hiroaki Nagashima, Yoshihiro Tsukamoto, Makoto Ideguchi, Kazuhiko Kurozumi, Tomohiro Hosoya, Atsushi Kambe
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction Multidrug chemoimmunotherapy with rituximab, high-dose methotrexate, procarbazine and vincristine (R-MPV) is a standard therapy for younger patients with primary central nervous system lymphoma (PCNSL); however, prospective data regardin
Externí odkaz:
https://doaj.org/article/19a3f93622fa498a96c3eec56dc02310
Autor:
Makoto Ideguchi, Takafumi Nishizaki, Norio Ikeda, Natsumi Fujii, Machiko Ohno, Taichi Shimabukuro, Tokuhiro Kimura, Eiji Ikeda, Kazuyoshi Suga
Publikováno v:
Interdisciplinary Neurosurgery, Vol 27, Iss , Pp 101364- (2022)
Introduction: The objective of the study was to investigate the correlation between differences between imaging modalities and histological heterogeneity in minimally enhancing glioma. Methods: A prospective study was performed in 11 patients with mi
Externí odkaz:
https://doaj.org/article/64581d4555884d40ba2ed50d2147eed7
Autor:
Masao Matsutani, Makoto Ideguchi, Akira Satoh, Hitoshi Tabata, Takayuki Kitamura, null Members of Support Team for Returning to Work
Publikováno v:
Japanese Journal of Stroke. 44:615-624
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0fccd3adfdb9b88ee7da9af8d276fb1
https://doi.org/10.3995/jstroke.11031
https://doi.org/10.3995/jstroke.11031
Autor:
Fumiyuki Yamasaki, Hirotaka Fudaba, Kenichiro Asano, Takashi Sasayama, Manabu Natsumeda, Taichi Shimabukuro, Kotaro Taguchi, Shinichiro Koizumi, Noriyuki Nakayama, Kentaro Fujii, Ikuno Nishibuchi, Kazuhiko Sugiyama, Kenji Yoshida, Ushio Yonezawa, Momii Yasutomo, Yukari Kawasaki, Kiyohide Kakuta, Kosuke Katayama, Kazuhiro Tanaka, Hiroaki Nagashima, Yoshihiro Tsukamoto, Makoto Ideguchi, Takafumi Nishizaki, Kazuhiko Kurozumi, Tomohiro Hosoya, Tomoyuki Akita, Atsushi Kambe
Publikováno v:
BMJ Open. 13:e071350
IntroductionMultidrug chemoimmunotherapy with rituximab, high-dose methotrexate, procarbazine and vincristine (R-MPV) is a standard therapy for younger patients with primary central nervous system lymphoma (PCNSL); however, prospective data regarding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33b3cb749d6492e724f4f957a148b807
https://doi.org/10.1136/bmjopen-2022-071350
https://doi.org/10.1136/bmjopen-2022-071350
Autor:
Masao Matsutani, Makoto Ideguchi, Takayuki Kitamura, Hitoshi Tabata, Daijiro Okamura, Shogo Yamamoto, Takeshi Maeda, Momoka Kato
Publikováno v:
Japanese Journal of Neurosurgery. 30:859-870
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38623c560dee06fc377b6a175fa8d4df
https://doi.org/10.7887/jcns.30.859
https://doi.org/10.7887/jcns.30.859
Autor:
Machiko Ohno, Norio Ikeda, Eiji Ikeda, Makoto Ideguchi, Kazuyoshi Suga, Taichi Shimabukuro, Takafumi Nishizaki, Natsumi Fujii, Tokuhiro Kimura
Publikováno v:
Interdisciplinary Neurosurgery, Vol 27, Iss, Pp 101364-(2022)
Introduction: The objective of the study was to investigate the correlation between differences between imaging modalities and histological heterogeneity in minimally enhancing glioma. Methods: A prospective study was performed in 11 patients with mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23577f56e15cda491d6f1cb2da52808d
http://www.sciencedirect.com/science/article/pii/S2214751921002760
http://www.sciencedirect.com/science/article/pii/S2214751921002760
Autor:
Makoto Ideguchi, Masao Matsutani, Takayuki Kitamura, Akira Sato, Syoichi Ito, Syoichi Muraya, Yuki Imaizumi, Akiko Omata
Publikováno v:
Neuro-Oncology Advances. 4:iii19-iii19
Introduction It is important for brain tumor and stroke patients to evaluate not only prognosis but also health related QOL (HRQoL). In this study, we have evaluated HRQoL and reviewed the related factors to improve HRQoL through in hospital to after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d81605419e11601264781fabdd56b69e
https://doi.org/10.1093/noajnl/vdac167.071
https://doi.org/10.1093/noajnl/vdac167.071
Publikováno v:
Neuro-oncology Advances
While there are many reports that long-term survivors of low-grade glioma patients treated with radiation therapy cannot lead a healthy social life due to cognitive dysfunction, we report a low-grade glioma patient with almost normal cognitive functi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6d09eefa330c50bca048040ddededb
http://europepmc.org/articles/PMC8648225
http://europepmc.org/articles/PMC8648225
Autor:
Hiroyuki Kida, Sadahiro Nomura, Mizuya Shinoyama, Makoto Ideguchi, Yuji Owada, Michiyasu Suzuki
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68877 (2013)
Hypothermia has been proposed as a treatment for reducing neuronal damage in the brain induced by hypoxic ischemia. In the developing brain, hypoxic ischemia-induced injury may give rise to cerebral palsy (CP). However, it is unknown whether hypother
Externí odkaz:
https://doaj.org/article/b6b2067226e64dfca90dc69bc76bb294
Publikováno v:
Neuro-oncology Advances
OBJECTIVE: Brain tumor patients with KPS of 60 to 30 after the initial treatment are not able to spend independent life at home. The goal of this study is to return these patients to their home with minimal family support by delivering intensive reha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::005a1470714844f29a2201e30bc84022
http://europepmc.org/articles/PMC8648154
http://europepmc.org/articles/PMC8648154